Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAG | P20916 | 5/20 | 0.55 |
| ▸ | SIGLEC7 | Q9Y286 | 2/20 | 0.55 |
| ▸ | SELL | P14151 | 1/20 | 0.52 |
| ▸ | SELP | P16109 | 1/20 | 0.52 |
| ▸ | CD22 | P20273 | 12/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29376477 | 0.93 | MAG (0.56) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL25658072 | 0.93 | SIGLEC7 (0.57) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL29379331 | 0.93 | MAG (0.58) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL23857822 | 0.93 | MAG (0.62) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL29361397 | 0.93 | MAG (0.62) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL27420912 | 0.92 | SIGLEC7 (0.56) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL21570084 | 0.91 | SIGLEC7 (0.62) | MAGSIGLEC7SELLSELP | |
| SCHEMBL28957979 | 0.91 | SIGLEC7 (0.62) | MAGSIGLEC7SELLSELP | |
| SCHEMBL21570085 | 0.91 | SIGLEC7 (0.62) | MAGSIGLEC7SELLSELP | |
| SCHEMBL28957980 | 0.91 | SIGLEC7 (0.62) | MAGSIGLEC7SELLSELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240216406-A1 | METHODS AND COMPOSITIONS FOR SUPPORTING HUMAN HEALTH DURING SPACE TRAVEL | INTRINSIC MEDICINE INC (US) | 2024-07-04 | — | — | US | disclosed |
| CN-117778496-A | Method for purifying sialylated oligosaccharides | 科汉森母乳低聚糖股份有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-116940587-A | Sialyltransferase for producing 6' -sialyllactose | 科汉森母乳低聚糖股份有限公司 | 2023-10-24 | — | — | CN | disclosed |
| US-20230201228-A1 | IMMUNOMODULATORY OLIGOSACCHARIDES | UNIV CALIFORNIA (US) | 2023-06-29 | — | — | US | disclosed |
| US-20230201228-A1 | IMMUNOMODULATORY OLIGOSACCHARIDES | UNIV CALIFORNIA (US) | 2023-06-29 | — | — | US | disclosed |
| US-20230181609-A1 | IMMUNOMODULATORY OLIGOSACCHARIDES | UNIV CALIFORNIA (US) | 2023-06-15 | — | — | US | disclosed |
| US-20220218727-A1 | METHODS AND COMPOSITIONS OF SUPPORTING HUMAN HEALTH DURING SPACE TRAVEL | INTRINSIC MEDICINE, INC. | 2022-07-14 | — | — | US | disclosed |
| US-20220193099-A1 | IMMUNOMODULATORY OLIGOSACCHARIDES FOR THE TREATMENT OF PAIN | TARGET CAPITAL 4 LLC | 2022-06-23 | — | — | US | disclosed |
| US-20210236526-A1 | IMMUNOMODULATORY OLIGOSACCHARIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-08-05 | — | — | US | disclosed |
| US-20210236527-A1 | IMMUNOMODULATORY OLIGOSACCHARIDES | UNIV CALIFORNIA (US) | 2021-08-05 | — | — | US | disclosed |
| US-20200237793-A1 | IMMUNOMODULATORY OLIGOSACCHARIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-07-30 | — | — | US | disclosed |
| US-20200230161-A1 | IMMUNOMODULATORY OLIGOSACCHARIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220193099-A1 | IMMUNOMODULATORY OLIGOSACCHARIDES FOR THE TREATMENT OF PAIN | FUT6, CSGALNACT1, FUT5 | MAG 24/4885SIGLEC7 19/4885SELL 142/4885 |
| US-20230201228-A1 | IMMUNOMODULATORY OLIGOSACCHARIDES | CD47, ICOS, CD74 | MAG 141/4885SIGLEC7 8/4885SELL 146/4885 |
| US-20200237793-A1 | IMMUNOMODULATORY OLIGOSACCHARIDES | CD47, ICOS, CD74 | MAG 141/4885SIGLEC7 8/4885SELL 146/4885 |
| US-20200230161-A1 | IMMUNOMODULATORY OLIGOSACCHARIDES | CD47, ICOS, CD74 | MAG 141/4885SIGLEC7 8/4885SELL 146/4885 |
| US-20230181609-A1 | IMMUNOMODULATORY OLIGOSACCHARIDES | CD47, ICOS, CD74 | MAG 141/4885SIGLEC7 8/4885SELL 146/4885 |
| US-20240216406-A1 | METHODS AND COMPOSITIONS FOR SUPPORTING HUMAN HEALTH DURING SPACE TRAVEL | FUT6, FUT5, FUCA2 | MAG 489/4885SIGLEC7 195/4885SELL 709/4885 |
| US-20210236526-A1 | IMMUNOMODULATORY OLIGOSACCHARIDES | CD47, ICOS, CD74 | MAG 141/4885SIGLEC7 8/4885SELL 146/4885 |
| US-20210236527-A1 | IMMUNOMODULATORY OLIGOSACCHARIDES | CD47, ICOS, CD74 | MAG 141/4885SIGLEC7 8/4885SELL 146/4885 |
| US-20220218727-A1 | METHODS AND COMPOSITIONS OF SUPPORTING HUMAN HEALTH DURING SPACE TRAVEL | FUT6, FUT5, FUCA2 | MAG 525/4885SIGLEC7 195/4885SELL 655/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.